Clinical Research
How CROs are Driving Pharmaceutical R&D
Global pharmaceutical giants rely on the burgeoning Contract Research Organization CRO sector to accelerate
Biomarkers for Cardiovascular diseases
A brief insight
Cardiovascular disorders CVDs including peripheral vascular disease
Enhancing Pharmacovigilance through the Scope of Artificial Intelligence
AI with its advanced analytical capabilities has shown promising potential in enhancing pharmacovigilance throughout the drug life
Ensuring Safety in Geriatric Medicine Use
Explicit criteria to avoid potentially inappropriate medication
Higher life expectancy among Asian people leads to a high number of elderly aged and over nowadays
ANTS: NON-INVASIVE TECHNIQUE FOR EARLY DETECTION OF CANCER
Early detection of cancer is critical for successful treatment and improved patient outcomes
Measuring Vaccine Efficacy
The right endpoints are key to success
Development of pharmaceutical products requires generation of data that enable a comprehensive evaluation of benefit against potential risks
Towards Precision Medicine for Cancer Pain Treatment in Asian Populations
The prevalence of cancer pain is high among patients with advanced cancer affecting up to per cent of patients which significantly impacts their quality of life
Real-World Evidence and the Drug Development Process
Dealing with ‘Pipeline Vision’
Drug development today is a risky and expensive business Drug discovery and development exhibits a per cent failure rate that as a process can take between years and whose average cost is US billionnewly approved drug
Enabling Digital and Decentralised Solutions in Clinical Research
Writing decentralised clinical trials into the protocol!
In recent years clinical research trial designs have started to change from fully paper and brick mortar sites traditional trials to digitalenabled designs utilising decentralised solutions which allow participant visits to be conducted remotely with some visits on site hybrid design or all visit decentralised from designated brickandmortar sites...
Role of miRNAs in Neurodegeneration
In disease causing mechanisms and tools of biomarker discovery and therapeutics
Neurodegenerative diseases such as Alzheimers disease AD Parkinsons disease PD Huntingtons disease HD and Amyotrophic lateral sclerosis ALS are a group of agerelated progressive disorders initiated by the neuronal loss that eventually leads to cognitive and movement disorders
